• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥大细胞的稳态和 JAK-STAT 通路。

Mast cell homeostasis and the JAK-STAT pathway.

机构信息

Department of Biology and VCU Allergy and Allergic Disease Cooperative Research Center, Virginia Commonwealth University, Richmond, VA 23284, USA.

出版信息

Genes Immun. 2010 Dec;11(8):599-608. doi: 10.1038/gene.2010.35. Epub 2010 Jun 10.

DOI:10.1038/gene.2010.35
PMID:20535135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3099592/
Abstract

The Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway mediates important responses in immune cells. Activation of any of the four JAK family members leads to phosphorylation of one or more of seven STAT family members. Phosphorylation of STAT family members leads to their dimerization and translocation into the nucleus, in which they bind specific DNA sequences to activate gene transcription. Regulation of JAKs and STATs therefore has a significant effect on signal transduction and subsequent cellular responses. Mast cells are important mediators of allergic disease and asthma. These cells have the ability to cause profound inflammation and vasodilation upon the release of preformed mediators, as well as subsequent synthesis of new inflammatory mediators. The regulation of mast cells is therefore of intense interest for the treatment of allergic disease. An important regulator of mast cells, STAT5, is activated downstream of the receptors for immunoglobulin E, interleukin-3 and stem cell factor. STAT5 contributes to mast cell homeostasis, by mediating proliferation, survival, and mediator release. Regulators of the JAK-STAT pathway, such as the suppressors of cytokine signaling (SOCS) and protein inhibitor of activated STAT (PIAS) proteins, are required to fine tune the immune response and maintain homeostasis. A better understanding of the role and regulation of JAKs and STATs in mast cells is vital for the development of new therapeutics.

摘要

Janus 激酶/信号转导和转录激活因子(JAK-STAT)途径介导免疫细胞中的重要反应。任何四种 JAK 家族成员的激活都会导致一个或多个 STAT 家族成员的磷酸化。STAT 家族成员的磷酸化导致它们二聚化并易位到细胞核内,在细胞核内它们结合特定的 DNA 序列以激活基因转录。因此,JAK 和 STAT 的调节对信号转导和随后的细胞反应有重大影响。肥大细胞是过敏疾病和哮喘的重要介质。这些细胞在释放预先形成的介质以及随后合成新的炎症介质后,具有引起深刻炎症和血管扩张的能力。因此,肥大细胞的调节对于过敏疾病的治疗具有强烈的兴趣。STAT5 是一种重要的肥大细胞调节剂,它是免疫球蛋白 E、白细胞介素-3 和干细胞因子受体下游的激活物。STAT5 通过介导增殖、存活和介质释放来介导肥大细胞的动态平衡。JAK-STAT 途径的调节剂,如细胞因子信号转导抑制物(SOCS)和激活 STAT 的蛋白抑制剂(PIAS)蛋白,是精细调节免疫反应和维持动态平衡所必需的。更好地了解 JAK 和 STAT 在肥大细胞中的作用和调节对于开发新的治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1f/3099592/64733ed5f373/nihms281242f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1f/3099592/d2aec03514a3/nihms281242f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1f/3099592/64733ed5f373/nihms281242f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1f/3099592/d2aec03514a3/nihms281242f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf1f/3099592/64733ed5f373/nihms281242f2.jpg

相似文献

1
Mast cell homeostasis and the JAK-STAT pathway.肥大细胞的稳态和 JAK-STAT 通路。
Genes Immun. 2010 Dec;11(8):599-608. doi: 10.1038/gene.2010.35. Epub 2010 Jun 10.
2
Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis and Baseline Signaling Profile Associates With Treatment Response.托法替尼抑制类风湿关节炎中的几个 JAK-STAT 通路,且基线信号特征与治疗反应相关。
Front Immunol. 2021 Sep 24;12:738481. doi: 10.3389/fimmu.2021.738481. eCollection 2021.
3
Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.定义 JAK-STAT 通路在头颈部和胸部恶性肿瘤中的作用:对未来治疗方法的影响。
Drug Resist Updat. 2010 Jun;13(3):67-78. doi: 10.1016/j.drup.2010.04.001. Epub 2010 May 14.
4
Inteferons pen the JAK-STAT pathway.干扰素开启JAK-STAT信号通路。 (注:原文中“ Inteferons ”应改为“ Interferons” )
Semin Cell Dev Biol. 2008 Aug;19(4):311-8. doi: 10.1016/j.semcdb.2008.08.010. Epub 2008 Aug 26.
5
JAK/STAT: Why choose a classical or an alternative pathway when you can have both?JAK/STAT:当你可以同时拥有经典途径和替代途径时,为什么还要选择其中之一呢?
J Cell Mol Med. 2022 Apr;26(7):1865-1875. doi: 10.1111/jcmm.17168. Epub 2022 Mar 3.
6
Malignant JAK-signaling: at the interface of inflammation and malignant transformation.恶性JAK信号传导:炎症与恶性转化的交汇点
Leukemia. 2025 May;39(5):1011-1030. doi: 10.1038/s41375-025-02569-8. Epub 2025 Mar 26.
7
Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.致癌性 KIT 突变体激活 STAT 蛋白的机制。
J Biol Chem. 2011 Feb 25;286(8):5956-66. doi: 10.1074/jbc.M110.182642. Epub 2010 Dec 6.
8
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.
9
Dynamics and non-canonical aspects of JAK/STAT signalling.JAK/STAT 信号转导的动力学和非经典方面。
Eur J Cell Biol. 2012 Jun-Jul;91(6-7):524-32. doi: 10.1016/j.ejcb.2011.09.005. Epub 2011 Oct 21.
10
Evolution of JAK-STAT pathway components: mechanisms and role in immune system development.JAK-STAT 通路成分的进化:机制及其在免疫系统发育中的作用。
PLoS One. 2012;7(3):e32777. doi: 10.1371/journal.pone.0032777. Epub 2012 Mar 7.

引用本文的文献

1
Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation.神经炎症是子宫内膜异位症疼痛的原因——靶向JAK-STAT通路和肥大细胞活化。
Front Immunol. 2025 Aug 29;16:1621178. doi: 10.3389/fimmu.2025.1621178. eCollection 2025.
2
Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis.子宫内膜异位症中补体与凝血级联反应的相互作用及Janus激酶抑制剂的潜力——一项网状Meta分析
Front Immunol. 2025 Jul 8;16:1619434. doi: 10.3389/fimmu.2025.1619434. eCollection 2025.
3
Naturally derived bioactive compounds as regulators of oxidative stress and inflammation in asthma.

本文引用的文献

1
Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V.活化 STAT5 在系统性肥大细胞增多症中肿瘤性肥大细胞中的表达:转化癌蛋白 KIT D816V 的亚细胞分布和作用。
Am J Pathol. 2009 Dec;175(6):2416-29. doi: 10.2353/ajpath.2009.080953. Epub 2009 Nov 5.
2
Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs.鉴定促凋亡蛋白 Bim 作为致瘤性肥大细胞中的肿瘤抑制因子:KIT D816V 的作用以及各种靶向药物的影响。
Blood. 2009 Dec 17;114(26):5342-51. doi: 10.1182/blood-2008-08-175190. Epub 2009 Oct 22.
3
天然衍生的生物活性化合物作为哮喘中氧化应激和炎症的调节剂
Chin Med. 2025 Jul 1;20(1):94. doi: 10.1186/s13020-025-01142-w.
4
Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies.变应原免疫疗法:陷阱、益处及意外助力
Int J Mol Sci. 2025 Apr 9;26(8):3535. doi: 10.3390/ijms26083535.
5
Expression levels of protein inhibitor of activated STAT (PIAS) family genes in Parkinson's disease patients: results from a case-control study.帕金森病患者中活化STAT蛋白抑制剂(PIAS)家族基因的表达水平:一项病例对照研究的结果
Acta Neurol Belg. 2025 Feb 28. doi: 10.1007/s13760-025-02752-9.
6
Signaling pathways and targeted therapy for rosacea.酒渣鼻的信号通路和靶向治疗。
Front Immunol. 2024 Sep 16;15:1367994. doi: 10.3389/fimmu.2024.1367994. eCollection 2024.
7
The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells.JAK1/JAK2 抑制剂芦可替尼可抑制人嗜碱性粒细胞和肥大细胞介质的释放。
Front Immunol. 2024 Aug 12;15:1443704. doi: 10.3389/fimmu.2024.1443704. eCollection 2024.
8
Role of Mast Cells in Eosinophilic Gastrointestinal Diseases.肥大细胞在嗜酸性粒细胞性胃肠道疾病中的作用。
Immunol Allergy Clin North Am. 2024 May;44(2):311-327. doi: 10.1016/j.iac.2024.01.004. Epub 2024 Feb 19.
9
The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies.STAT3 和 STAT1 在癌症生物学中的互补作用:对肿瘤发病机制和治疗策略的深入了解。
Front Immunol. 2023 Nov 8;14:1265818. doi: 10.3389/fimmu.2023.1265818. eCollection 2023.
10
The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model.针对缺氧诱导因子-1α(HIF-1α)和信号转导与转录激活因子5(STAT5)的诱饵寡脱氧核苷酸改善了特应性皮炎样小鼠模型。
Mol Ther Nucleic Acids. 2023 Sep 20;34:102036. doi: 10.1016/j.omtn.2023.102036. eCollection 2023 Dec 12.
IL-5- and eosinophil-mediated inflammation: from discovery to therapy.
白细胞介素 5-和嗜酸性粒细胞介导的炎症:从发现到治疗。
Int Immunol. 2009 Dec;21(12):1303-9. doi: 10.1093/intimm/dxp102. Epub 2009 Oct 9.
4
Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.慢性骨髓增殖性肿瘤中磷酸化 STAT5 和磷酸化 Akt 的表达。
Br J Haematol. 2009 Nov;147(4):495-506. doi: 10.1111/j.1365-2141.2009.07870.x. Epub 2009 Aug 31.
5
Targeting PI3K signalling in cancer: opportunities, challenges and limitations.靶向癌症中的PI3K信号通路:机遇、挑战与局限
Nat Rev Cancer. 2009 Aug;9(8):550-62. doi: 10.1038/nrc2664.
6
JAK2 inhibitors: not the next imatinib but researchers see other possibilities.JAK2抑制剂:虽非下一个伊马替尼,但研究人员看到了其他可能性。
J Natl Cancer Inst. 2009 Jul 15;101(14):980-2. doi: 10.1093/jnci/djp216. Epub 2009 Jul 7.
7
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.342例连续成年系统性肥大细胞增多症患者的生存研究及预后因素
Blood. 2009 Jun 4;113(23):5727-36. doi: 10.1182/blood-2009-02-205237. Epub 2009 Apr 10.
8
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.世界卫生组织(WHO)髓系肿瘤和急性白血病分类的2008年修订版:基本原理及重要变化
Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8.
9
The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.c-Kit的D816V突变规避了c-Kit信号转导中对Src家族激酶的需求。
J Biol Chem. 2009 Apr 24;284(17):11039-47. doi: 10.1074/jbc.M808058200. Epub 2009 Mar 5.
10
Endogenous suppression of mast cell development and survival by IL-4 and IL-10.白细胞介素-4和白细胞介素-10对肥大细胞发育和存活的内源性抑制作用。
J Leukoc Biol. 2009 May;85(5):826-36. doi: 10.1189/jlb.0708448. Epub 2009 Feb 19.